Prokidney (PROK) executive compensation, 2026 proxy

Bruce Culleton, M.D., Chief Executive Officer, was paid $3M in 2025, up 191% from $1M the year before.

Filed
April 17, 2026
Annual meeting
May 28, 2026
Pay year
2025
Named executives
3
CEO total pay
$3M+191% vs prior year
2025 Corporate Goal Achievement
120%Approved by Talent and Compensation Committee
CEO Target Bonus Opportunity
60%Percentage of base salary
NEO Target Bonus Opportunity
45%For Chief Legal Officer and CFO
CEO 2025 Option Awards
$1,775,166Grant date fair value

How M.D. was paid

$3M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary23%Option awards60%Non-equity incentive16%All other compensation1%

Named executive officers

ExecutiveTotal
Bruce Culleton, M.D.Chief Executive Officer$2,956,447
Todd C. GirolamoChief Legal Officer$1,367,562
James CoulstonChief Financial Officer$1,367,332

What changed and why

  • $3MCEO Bruce Culleton received total compensation of $2,956,447 in 2025, an increase from $1,015,802 in 2024.
  • 120%The Talent and Compensation Committee approved a corporate goal achievement level of 120% for 2025.
  • $664KDr. Culleton entered into a new employment agreement on May 12, 2025 providing a base salary of not less than $664,000.
  • $450KTodd C. Girolamo and James Coulston each received base salaries of $450,000 under new agreements entered into in May 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.